Adcetris (brentuximab vedotin) can impact patients with kidney issues. Those with severe kidney impairment might experience more frequent and severe side effects compared to individuals with normal kidney function. As a result, Adcetris is not recommended for patients with severe renal impairment, defined as having a creatinine clearance of less than 30 mL/min, due to the risk of increased toxicity.
